Focus
Gilead Sciences
LATEST
Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices
Gilead is accused of ‘downplaying or omitting altogether the clinical dangers experienced by patients from remdesivir use.’
|
Remdesivir Therapy Has ‘Little Effect’ on COVID-19 Mortality: WHO Study
Remdesivir therapy, an experimental antiviral therapy that has been used to treat COVID-19, has no substantial effect on a patient’s chances of survival.
|
|
